| Page 96 | Rogel Cancer Center | University of Michigan

skip to main content

Tumor cells reprogram metabolic pathways in order to grow Researchers at the U-M Rogel Cancer Center have discovered the process that allows immune suppressor cells to develop, suggesting a potential new way to bolster immunotherapy treatment. Read more about Tumor cells reprogram metabolic pathways in order to grow	Center of Excellence for Cancer Immunology and Immunotherapy The Center of Excellence for Cancer Immunology and Immunotherapy (CECII) was founded in 2018 under the directorship of Dr. Weiping Zou. The center is an interdisciplinary and multi-department collaborative effort to enforce human immunology research and accelerate translation of basic advances in cancer immunology into clinical therapies that improve care for cancer patients through interdisciplinary research. Read more about Center of Excellence for Cancer Immunology and Immunotherapy	Spine Oncology The content on this page has moved. Please visit Spine Oncology at the University of Michigan for more information. Read more about Spine Oncology	Personalizing Lung Cancer Screening A new study shows how to personalize the lung cancer screening decision for every patient. The results could help doctors fine-tune their advice to patients so that it’s based not only on a patient’s individual lung cancer risk and the potential benefits and harms of screening, but also the patient’s attitude about looking for problems and dealing with the consequences. Read more about Personalizing Lung Cancer Screening
U-M partners with nation’s top cancer centers to endorse goal of eliminating HPV-related cancers The University of Michigan Rogel Cancer Center has partnered with 69 other National Cancer Institute-designated cancer centers to issue a statement urging for increased HPV vaccination and screening to eliminate HPV-related cancers, starting with cervical cancer. Read more about U-M partners with nation’s top cancer centers to endorse goal of eliminating HPV-related cancers	Radiation Oncology for Prostate Cancer Highly Targeted Radiotherapy for Better Quality of Life The University of Michigan radiation oncology team offers the most advanced, highly accurate radiation treatments for prostate cancer. These advances are possible thanks to our dedication to the latest prostate cancer research and clinical trials where new diagnostic and treatment techniques are constantly studied and developed. Read more about Radiation Oncology for Prostate Cancer	Bladder Cancer Research Dedication to Bladder Cancer Research and Discovery The University of Michigan Rogel Cancer Center is dedicated to cancer research and discovery. That includes bladder cancer, which impacts roughly 80,000 adults in the United States each year. Read more about Bladder Cancer Research	Bladder Cancer Treatment The University of Michigan Rogel Cancer Center offers a wide array of treatment options for bladder cancer patients. Whether it’s chemotherapy, radiation, minimally invasive surgery, open surgery or a combination of multiple therapies, our multidisciplinary care teams will design the right treatment course based on your personalized care needs Read more about Bladder Cancer Treatment
U-M Rogel Cancer Center first in Michigan to offer all FDA approved CAR T-cell therapies Media contact: Jessica Webster-Sendra, 734-764-2220 \| Patients may contact Cancer AnswerLine, 800-865-1125 ANN ARBOR, Michigan — With the recently announced FDA approval of Kymriah to treat adults with lymphoma, the University of Michigan Rogel Cancer Center is the first center in Michigan to offer all currently available CAR T-cell therapies. Read more about U-M Rogel Cancer Center first in Michigan to offer all FDA approved CAR T-cell therapies	2018 Senior Forbes Scholars The information on this page has moved. Please visit the Previous Scholars page to learn more. Read more about 2018 Senior Forbes Scholars

Pages